{"anticipatedPostingDate":"2009-12","denoms":[{"counts":[{"groupId":"OG000","value":"0"}],"units":"Participants"}],"description":"Measurement of peak concentrations of 852A to correlate the side effects of tolerability in patients.","groups":[{"description":"Patients receiving at least 12 doses of 852A.","id":"OG000","title":"852A Treatment"}],"populationDescription":"Not able to analysis due to sale of agent - unable to perform.","reportingStatus":"POSTED","timeFrame":"Up to Week 12","title":"Peak Concentrations of 852A","type":"SECONDARY"}